LC3 ‐positive extracellular vesicles released from tumor cells promote lung metastasis of breast cancer by inducing vascular permeability
The FEBS Journal · 2025
DOI: 10.1111/febs.70335 ↗Kurz gefasst
Fachartikel in der Zeitschrift The FEBS Journal, 2025. Verfasst von Yuqing Shen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, School of Medicine, Jiangsu Provincial Key Laboratory of Critical Care Medicine, Southeast University, Nan…. Hauptthemen laut MEDLINE: Breast Neoplasms, Lung Neoplasms, Extracellular Vesicles, Capillary Permeability. Die Arbeit nennt 35 Literaturangaben. Gefördert von: Jiangsu Provincial Key Laboratory of Critical Care Medicine, Major Research Plan of the National Natural Science Foundation of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Tight junctions (TJs) between pulmonary vascular endothelial cells (ECs) constitute the physical barrier that impedes the metastasis of tumor cells. We previously reported that circulating microtubule‐associated proteins 1A/1B light chain 3B (LC3)‐positive extracellular vesicles (LC3 + EVs) derived from primary breast tumors were essential for establishing the premetastatic niche. However, the roles of LC3 + EVs in inducing vascular permeability and promoting tumor metastasis are unclear. In this study, we revealed that the expression of occludin and tight junction protein 1 [also known as zona occludens protein 1 (ZO‐1)], two major TJ proteins, could be reduced by circulating LC3 + EVs, which subsequently increased vascular permeability, facilitated the invasion of circulating tumor cells, and eventually resulted in increased lung metastasis. Heat shock protein 60 (HSP60) was identified as the key molecule on LC3 + EVs that induced the reduction of occludin and ZO‐1 through the Toll‐like receptor 2 (TLR2)–myeloid differentiation primary response protein MyD88 (MYD88)–Snail Family Transcriptional Repressor 1 (Snai1) signal cascade. Combined with our previous findings, these results demonstrate that removing circulating LC3 + EVs or targeting HSP60 on LC3 + EVs might be a promising way to prevent breast cancer lung metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, School of Medicine, Jiangsu Provincial Key Laboratory of Critical Care Medicine, Southeast University, Nanjing, China.
- Key Laboratory of Developmental Genes and Human Disease, Ministry of Education, Southeast University, Nanjing, China.
ORCID-Profile: Jianqiong Zhang, Lixin Wang
Förderung
- Jiangsu Provincial Key Laboratory of Critical Care Medicine
- Major Research Plan of the National Natural Science Foundation of China
- National Natural Science Foundation of China
Zitieren
APA
Shen, Y., Shen, Y., Wang, X., Wang, F., Liu, P., Sun, C., Zhang, Y., Miao, F. Q., Zhang, J., & Wang, L. (2025). LC3 ‐positive extracellular vesicles released from tumor cells promote lung metastasis of breast cancer by inducing vascular permeability. The FEBS Journal. https://doi.org/10.1111/febs.70335
Vancouver
Shen Y, Shen Y, Wang X, Wang F, Liu P, Sun C, et al. LC3 ‐positive extracellular vesicles released from tumor cells promote lung metastasis of breast cancer by inducing vascular permeability. The FEBS Journal. 2025. doi:10.1111/febs.70335
BibTeX
@article{Shen2025,
author = {Shen, Yuqing and Shen, Yi and Wang, Xuru and Wang, Fuhua and Liu, Piaopiao and Sun, Chen and Zhang, Ying and Miao, Feng-Qin and Zhang, Jianqiong and Wang, Lixin},
title = {LC3 ‐positive extracellular vesicles released from tumor cells promote lung metastasis of breast cancer by inducing vascular permeability},
journal = {The FEBS Journal},
year = {2025},
doi = {10.1111/febs.70335}
}
EUVIMED